$ICHR

Swyt Greg sold $120K of ICHR

Swyt Greg (Chief Financial Officer) sold 2,068 shares of ICHOR HOLDINGS, LTD. (ICHR) at $58.02 ($0.12M total) on 2026-09-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Swyt Greg
Published Sep 8, 2026, 11:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 11:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ICHR
Neutral
high confidence
Mentioned
$ICHR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ICHRNeutralLow
01

Why it matters

The disclosed sale is modest and pre‑arranged, offering little new actionable insight for traders.

02

Market read

Limited relevance; primarily of interest to existing shareholders monitoring insider activity.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed in the filing.

Relevance 3/10Novelty 3/10Timing: same day

Background

Form 4 filing from SEC EDGAR reporting an insider sale by ICHOR's CFO.

Company-level read

Ticker impact

$ICHRNeutralHigh confidence
Context

CFO Swyt Greg sold 2,068 shares of ICHOR for $119,985 via a 10b5-1 plan, reducing his stake to 47,832 shares.

Expected impact

minimal downward pressure

Evidence & confidence

Sale size is small relative to market cap and disclosed under a pre‑arranged plan, suggesting no urgent insider concern.

Market effects

None; the transaction is company‑specific.

None; limited to ICHOR shareholders.

None; no broader market effect.

Counterpoint

The sale could be interpreted as a lack of confidence, but the 10b5‑1 plan suggests routine portfolio management.

Key entities

  • Swyt Greg

    Chief Financial Officer of ICHOR Holdings, Ltd.

  • ICHOR Holdings, Ltd.

    Biotech company listed on Nasdaq under ticker ICHR.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ICHRMedAI 8/10

Ichor Holdings, Ltd. Q2 2026 Earnings Call Summary

Ichor Holdings reported Q2 2026 revenue up 15% sequentially, with gross margin rising 130 bps to 14.1%. Management attributed a Q2 revenue shortfall to brief flow-control part shortages resolved after quarter end, shifting volume to Q3. It expects sequential revenue growth above 10% for the next two quarters and full-year 2026 revenue up at least 30% vs 2025, with gross margin gains of 100 bps per quarter. An ATM raised $195m net proceeds.

$ICHRMed

Why is Ichor Holdings stock sliding today?

Ichor Holdings (ICHR) shares fell 12.9% in after-hours after its Q2 2026 results. The company reported adjusted EPS of $0.34 on revenue of $294.8M, beating consensus, with gross margin at 14.1%. Operating cash flow was -$15.9M and it completed a $200M at-the-market offering. Q3 revenue guidance was $315M-$345M.

$PLTRMed

After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR

Investing.com’s after-hours movers report highlights Palantir (PLTR) up 10% after Q2 EPS of $0.41 and $1.94B revenue, with 2026 revenue guidance raised to $8.15–$8.158B. Snap (SNAP) rose 9.6% on Q2 revenue $1.6B and Q3 guidance $1.7–$1.74B. Backblaze (BLZE) gained 16% on Q2 beat and raised 2026 revenue to $172–$174M. ON (ON) +5%, ICHR -11%, WGS -7%, WHR -4%.

$ICHRMedAI 9/10

Ichor Holdings, Ltd. $ICHR Shares Bought by Royce & Associates LP

Royce & Associates LP increased its Ichor Holdings (NASDAQ:ICHR) stake by 48.5% in Q4 to 1,449,082 shares, worth $26.71M, after buying 473,440 shares, according to SEC filings cited by HoldingsChannel. Other institutions also added shares. CEO Philip Ryan Sr. Barros sold 21,000 shares at $46.63. Analysts raised price targets; consensus average is $64.57.